Ipsomedic
Develops pharmaceutical active-ingredient manufacturing processes for domestic production in France
Highlights
- New on EvolcAdded 2026-11-02
About Ipsomedic
Ipsomedic develops processes for manufacturing pharmaceutical active ingredients in France, with a focus on environmental impact, safety and economic viability. It aims to enable the use of these processes in French production facilities.
Its R&D site is in Aubagne, France. The company was founded in 2019.
Product: Research and development of processes for manufacturing pharmaceutical active ingredients in France.
Jobs at Ipsomedic
More biotech & pharma companies
JANVIER LABS
Supplies and manages experimental rodent models and related services for biomedical researchersNew on EvolcSalary transparentKimialys
Biosensing surface chemistry and lateral flow assay development for diagnostics and drug discovery labsNew on EvolcLFB Biomanufacturing
Contract development and GMP manufacturing of biologic drugs for biotech and pharma developers, from cell lines to clinicalNew on EvolcLys Therapeutics
Biotech developing an antibody to treat blood-brain barrier dysfunction and neuroinflammation in neurological diseasesNew on EvolcMaat Pharma
Develops microbiome-based cancer therapeutics for patients with severe oncology diseasesNew on EvolcMabqi
Discovers and develops therapeutic antibodies for biopharmaceutical partners and oncology treatment programsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
